SEC Form 4 · accession 0001250853-15-000108
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Bender
Officer — Vice President, Manufacturing
Period of report
Sep 30, 2015
Accepted (ET)
Dec 30, 2015 · 3:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001425205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 30, 2015 | F | 11,274 | $5.76 | D | 88,726 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.58 | Dec 28, 2015 | A | 27,622 | A | — | Dec 27, 2025 | Common Stock | 27,622 | 27,622 | D |
Explanation of responses
- F1One third of the shares underlying the option shall vest on December 28, 2016; and the remaining shares shall vest in eight equal quarterly installments over the next two years after the first anniversary of the grant date of December 28, 2015, provided the Reporting Person is still providing services to the Issuer on the respective dates.